SciClone Pharmaceuticals, Inc.

SciClone Pharmaceuticals, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States

: | Nasdaq: SCLN

Similar to: Transgene SA, BioAlliance Pharma SA, Nicox SA

SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders. The company operates its business through two segments: China and Rest of the World including United States. Its ZADAXIN product is approved in over 30 countries and used for the treatment of hepatitis B (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain cancers. SciClone Pharmaceuticals was founded in 1990 and is headquartered in Foster City, CA.

News & Analysis

You may also be interested in: